-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of the National Development and Reform Commission (NDRC) issued a notice on the release of the 2020 (27th batch) new identification and the list of all national enterprise technology centers (Reform High Technology (2020) No. 1918), including Beijing Ted Pharmaceutical Co., Ltd., 97 enterprise technology centers and 10 sub-centers, with national enterprise technology centers and sub-center qualifications.
Ted Pharmaceutical President Sun Yuhang introduced, after obtaining the national enterprise technology center qualification, the company has the opportunity to enjoy science and technology development supplies exempt from import tax, to assume the central financial science and technology plan (special, fund, etc.) research and development tasks and other policies and financial support.
Sun Yuhang told reporters that Ted Pharmaceuticals will spend 8% of its annual sales revenue on research and development innovation, has become the national leader in pharmaceutical research and development.
company around the new mechanism of innovative drugs, biological products, high-end preparations, high-end medical devices four business sectors, the development of domestic and even the world's leading innovative series of products, focusing on microcirculation, analgesics, respiratory, tumor four areas, with 300 patent applications for inventions, including pcT international patent applications more than 100.
It is learned that Beijing Ted Pharmaceutical Co., Ltd. was founded in 1995, located in the Beijing Economic and Technological Development Zone, is focused on the international leading high-end targeted preparation technology and biopharmaceutical field of high-tech pharmaceutical enterprises, is China's largest targeted drugs, modern external skin paste paste drug research and development and industrialization base.
company has been selected in the Ministry of Industry and Information Technology of China's top 100 pharmaceutical industry list for 7 consecutive years, in 2019 ranked 41st.
Since 2009, Beijing Economic and Technological Development Zone, which is home to large international and domestic enterprises such as Mercedes-Benz, Bayer and JD.com, has been ranked in the top five in terms of tax revenue, and has paid more than 7 billion yuan in taxes so far, making a positive contribution to Beijing's economic development.
, male, born in 1979, Jilin Province, is currently the president of Beijing Ted Pharmaceutical Co., Ltd.
Bachelor of Pharmacy, Master of Pharmaceutical Engineering, Australian National University MBA.
Vice President of China Chemical and Pharmaceutical Industry Association, Vice President of the National Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, Vice President of Beijing Pharmaceutical Industry Association, Special Research Fellow of the Academic Committee of the China Academy of Management Sciences.